Dr. Tongalp H. Tezel, MD

Dr. Tezel practices at Trustees of Columbia University in the City of New York in Fort Lee, New Jersey.

Dr. Tezel's NPI, 1306813522, was assigned on March 7, 2006. Dr. Tezel graduated from Hacettepe University FOM in 1984. Dr. Tezel's Kentucky license number on file is 38219.

Dr. Tezel's primary practice is Trustees of Columbia University in the City of New York, at 400 Kelby St, Fort Lee, NJ 07024 in Bergen County. The practice phone is (646) 317-7111.

Dr. Tezel's primary practice is Trustees of Columbia University in the City of New York in Fort Lee, New Jersey. Dr. Tezel is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Tezel to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tezel practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Tezel's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Tezel is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Tezel's licenses on file in 3 states: Kentucky, New York and Indiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, dry eye, glaucoma, hereditary corneal conditions, hypertensive retinopathy and laser destruction of retinal or choroid lesions among the conditions Dr. Tezel treats.

CMS data shows 7,654 Medicare services from Dr. Tezel across 12 procedure codes in 2024, for 633 Medicare patients. Medicare paid $557,875 for them.

CMS counts 633 Medicare patients who saw Dr. Tezel in 2024. The largest group is 75 to 84, with 269 patients. 75% of them have high cholesterol, and 66% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tezel's median patient age at 67, with 56% women.

In 2024, Dr. Tezel wrote 359 Medicare Part D claims for 79 patients. 61% of them were for generic drugs. CMS names the drug for 320 of them, across 8 drugs with 11 or more claims each, at $42,060 in total drug cost. In 2023, CMS named 251 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Tezel for performance year 2024, reported through an alternative payment model (APM). Dr. Tezel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 21 procedures of cataract surgery by Dr. Tezel, more than 46% of the clinicians it reports for that procedure.

Dmand AI links 52 papers to Dr. Tezel, published from 2003 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Tomography, Optical Coherence, Retina and Pigment Epithelium of Eye. Dr. Tezel has published most often in Invest Ophthalmol Vis Sci. Dr. Tezel's most frequent co-authors are Adam Scott Berger, MD, Lucian V. Del Priore, MD and Stanley Chang, MD.

CMS Open Payments shows 16 general payments to Dr. Tezel from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Dutch Ophthalmic, USA paid the most, $594.

Dmand AI lists 2 awards for Dr. Tezel.

Dr. Tezel graduated from Hacettepe University FOM in 1984. Dr. Tezel is a member of AOA, AAO, ASRS, The Association for Research in Vision and Ophthalmology, The Macula Society and The Retina Society.

Dr. Tezel is in network with 14 carriers, including Aetna, Elevance and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.